Clinical trial ICON
A randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | Oslo University Hospital |
EudraCT Identifier | 2017-000220-10 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03409198 |
Inclusion criteria | ER+/HER2-. Metastatic |
Last update |